1. "2016"
Formats
  1. Journal Article (2949)
  2. Meeting Abstract (1606)
  3. Book Section (155)
  4. Conference Paper (36)
  5. Book Whole (14)
Groups
  1. Department of Medicine (1963)
  2. GSK Faculty (1162)
  3. Solid Tumor Oncology Division (1064)
  4. Surgery (904)
  5. Survivorship Research (795)
  6. Center for Hematologic Malignancies (777)

More Groups

People
  1. Michael Berger (93)
  2. Jedd Wolchok (84)
  3. Robert Motzer (74)
  4. Sergio Giralt (73)
  5. Miguel-Angel Perales (69)
  6. Jose Baselga (67)

More People

Years
  1. 2016 (4760)
Publications
  1. Journal of Clinical Oncology (469)
  2. Blood (210)
  3. Modern Pathology (124)
  4. Laboratory Investigation (108)
  5. International Journal of Radiation Oncology, Biology, Physics (104)
  6. Annals of Oncology (94)

More Publications

Publishers
  1. Elsevier Inc. (519)
  2. American Society of Clinical Oncology (497)
  3. Springer (349)
  4. Nature Publishing Group (322)
  5. Oxford University Press (248)
  6. American Society of Hematology (213)

More Publishers

Results (4760)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Final phase IIa study results evaluating the CXCR4 antagonist BL-8040 in combination with cytarabine (Ara-C) for the treatment of relapsed/refractory AML patients
    Meeting Abstract

    Borthakur, G.; Tallman, M.; Ofran, Y.; Foran, J.; Uy, G.; DiPersio, J.; Nagler, A.; Rowe, J.; Showel, M.; Altman, J.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2016)

    Fulltext@MSK | Save
  • A chart review of lower dosing of ponatinib in patients with chronic myeloid leukemia (CML): Preliminary findings
    Meeting Abstract

    Mauro, M.; McGarry, L.; Inguilizian, A.; du Moulin, R.; Huang, H.
    Clinical Lymphoma, Myeloma and Leukemia (2016)

    Fulltext@MSK | Save
  • The PACE clinical trial vs the real-world: Comparison of ponatinib prescribing and duration of therapy in chronic-phase chronic myeloid leukemia (CP-CML) patients
    Meeting Abstract

    Mauro, M.; McGarry, L.; Yang, M.; Lustgarten, S.; Huang, H.
    Clinical Lymphoma, Myeloma and Leukemia (2016)

    Fulltext@MSK | Save
  • Rapid achievement of MR(4.5) after switching from imatinib to nilotinib in patients with chronic myeloid leukemia in chronic phase (CML-CP): Preliminary results from ENESTgoal
    Meeting Abstract

    Ritchie, E.; Deininger, M.; Erba, H.; Savona, M.; Paley, C.; Dautaj, I.; Mauro, M.
    Clinical Lymphoma, Myeloma and Leukemia (2016)

    Fulltext@MSK | Save
  • Phase I trial: CD19-targeted CAR T-cells in patients with residual CLL following initial purine analog-based therapy
    Meeting Abstract

    Geyer, M.; Park, J.; Rivière, I.; Senechal, B.; Hsu, M.; Wang, X.; Purdon, T.; Sadelain, M.; Brentjens, R.
    Clinical Lymphoma, Myeloma and Leukemia (2016)

    Fulltext@MSK | Save
  • Ponatinib therapy for Philadelphia-positive ALL (Ph+ ALL) patients: Real-world clinical practice vs the PACE trial
    Meeting Abstract

    Mauro, M.; McGarry, L.; Yang, M.; Lustgarten, S.; Huang, H.
    Clinical Lymphoma, Myeloma and Leukemia (2016)

    Fulltext@MSK | Save
  • CD47 blockade enhances therapeutic activity of TCR mimic antibodies to ultra-low density cancer epitopes
    Meeting Abstract

    Mathias, M.; Sockolosky, J.; Chang, A.; Liu, C.; Garcia, K.; Scheinberg, D.
    Clinical Lymphoma, Myeloma and Leukemia (2016)

    Fulltext@MSK | Save
  • Vulnerability & mental health challenges: Three case studies form local to global
    Journal Article

    Rosa, W.
    Beginnings (2016)

    Fulltext@MSK | Save
  • The will to live—and living well
    Journal Article

    Lim, F.; O'Leary, J.
    American Nurse Today (2016)

    Fulltext@MSK | Save
  • Spinal nerve tolerance to single-session stereotactic ablative radiation therapy (SABR)
    Meeting Abstract

    Medin, P. M.; Hrycushko, B. A.; Vernino, S.; Foster, R. D.; Sayre, J.; Yamada, Y.; Van der Kogel, A. J.
    International Journal of Radiation Oncology, Biology, Physics (2016)

    Fulltext@MSK | Save